The deal, one of the largest in the pharma industry, will place Takeda Pharma into the top ranks of global drugmakers. On Tuesday, in a strategic move Japan’s Takeda Pharma stated it has agreed to acquire London-listed Shire for $61.50… Read More ›
therapies
Novartis to acquire AveXis for $8.7 billion
The acquisition will add AveXis top drug to its repertoire of drugs, which has a significant market in the U.S. for spinal muscular atrophy. On Monday, Switzerland-based healthcare giant Novartis announced its $8.7 billion deal to acquire AveXis; Novartis will… Read More ›
manageria.biz 